FDA recall, , Moderate risk
Avet Methohexital Sodium for Injection
Methohexital Sodium for Injection failed impurities and degradation specifications.
Summary by Recall Canary from the FDA notice
What happened
ONESOURCE SPECIALTY PHARMA LIMITED, located in Bengaluru, India, recalled Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, because it failed impurities and degradation specifications. The product, manufactured for Avet Pharmaceuticals Inc., East Brunswick, NJ, was distributed nationwide within the United States. The recall began June 7, 2026, and was added to the FDA's Enforcement Report on July 7, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial
- NDC
- 23155-893-31
- Lot code
- 7000612A
Recall details
- Company began the recall
- Sold in
Nationwide within the United States
- Company
- ONESOURCE SPECIALTY PHARMA LIMITEDBengaluru, India
- Hazard
- Drug impurity
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99220
- Recall number
- D-0662-2026
- Quantity recalled
- 4284 vials
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
